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1. Introduction 
The appearance of the lungs of a cystic fibrosis (CF) patient at post mortem is typically one of 
consolidation, with areas of bronchiectasis filled with mucopurulent material and of mucus 
plugging of the small airways (Yankaskas et al., 2004). The airways of the upper respiratory 
tract have increased secretion production, whilst in the lower respiratory tract there is 
increased mucus production and an increase in sputum. This sputum is usually thick and 
tenacious, becoming thicker and more abundant during an exacerbation and leading to 
progressive lung damage. It is therefore essential that in patients with CF the process of airway 
clearance is enhanced, where needed, to attempt to reduce these long-term effects. 
The purpose of this chapter is to outline 1) the normal structure and function of the airways, 
2) the process of mucus clearance in normal airways, 3) the effects that CF has on both the 
physiology and mucus clearance, 4) the current understanding of airway clearance device in 
terms of how they work and their application and finally 6) to look towards the future.  
2. Structure and function in normal airways 
The structure of the airways, and hence the function of the airways is affected by disease 
(Ranga & Kleinerman, 1978). Understanding the structure of the normal airways and how 
CF changes the airway function is essential in understanding the potential application of 
airway clearance techniques in clinical practice.  
2.1 Normal airway structure 
The airways start at the trachea and terminate at the alveolar sacks where gas exchange 
takes place (Fig 1).   
There are about 23 branches of the airways from trachea to alveoli. The first 15 
generations do not play a role in gas exchange and constitute the anatomical dead space 
(~150 ml). Gas exchange commences from generation 15 onwards, with alveolar ducts 
appearing at generations 19 – 22. Generation 23 is the last generation of the airways, 
constituting the alveolar sacs. The total number of alveoli ranges from 200 to 600 million 
(mean 300 million), the number correlating with the standing height of the subject (Angus 
& Thurlbeck, 1972). 
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Fig. 1. Resin cast of a human lung showing the branching pattern of the bronchial tree (B) 
which originates from the trachea (T). In the left lung, the pulmonary arteries (A) and veins 
(V) are marked. The inset shows the peripheral airway branching at higher power. 
Reproduced with permission from Wiebel ER, The Pathway for Oxygen: Structure and 
Function in the Mammalian Respiratory System. Harvard University Press, London, 
England, 1984 
The bronchi contain cartilage which maintains airway patency, whilst the bronchioli have 
no cartilage (Fig 2). Histologically, the airway epithelium becomes thinner towards the 
alveoli, where the distance between the air in the alveoli and blood in the pulmonary 
capillaries is about 0.2 µm.  
 
Fig. 2. A) Organization of the airway tree, divided into conducting zones, the transitional 
and respiratory zones where alveolar begin to appear before leading to the alveolar ducts 
and sacs. Based on Weibel ER. Morphometry of the human Lung. Heidelberg: Springer. 
New York Academic, 1963. B) Ciliated epithelia cells and goblet cells occur in the larger 
airways, decreasing towards the smaller airways. Goblet cells are replaced in the transitional 
and conducting zones by Clara cells. Pores of Kohn appear in the alveolar walls and are 
important in terms of collateral ventilation.  
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Ciliated epithelial cells decrease in number and shape from the large airways towards the 
small airways. Goblet cells abound in the larger airways, with around 6000 mucus secreting 
cells.mm-2, and are responsible, along with the submucosal secretory cells, for producing the 
thick layer of mucus that lines all but the smallest of conducting airways. Mucin is rapidly 
released from the mucus-secreting cells in response to a range of stimuli including direct 
chemical irritation, inflammatory cytokines and neural activity (Rogers, 1994). The number 
of Goblet cells and their secretions increases significantly in CF. 
In the smaller airways, Goblet cells are replaced by Clara cells which constitute about 80% 
of the cell population. Clara cells may play a role in the Cystic Fibrosis transmembrane 
conductance regulator (CFTR) gene-dependant regulation of epithelial electrolyte and water 
secretion in addition to their roles of surfactant production, protection against oxidative 
stress and suppression of inflammation (Kulaksiz et al, 2002). CFTR expression is 
significantly greater in the respiratory and terminal bronchioles compared to the proximal 
airways and alveoli (Engelhardt et al, 1994). Smooth muscle in the airway wall gradually 
increases so that in the terminal bronchioles it constitutes around 20% of the wall 
thickness.  
2.2 Normal function 
The normal lung maintains sterility below the first bronchial division despite breathing in 
450 l.h-1 at rest of air contaminated with viruses and bacteria. To move this volume of gas, 
the ventilatory pump must create negative and positive pressures within the thorax for air 
to enter and leave, respectively. In addition, the pump must provide a system of distributing 
the inhaled gas to the alveoli, where blood supplied to the alveoli by the pulmonary 
circulation will come into contact with the alveolar gas. Hence, for gas exchange to take 
place 1) the lungs must be ventilated, 2) the pulmonary circulation must be perfused, and 3) 
the ventilation and perfusion must be matched. 
The airways present a major challenge to the movement of air from the atmosphere to the 
alveoli. The airways narrow with each branching, decreasing from about 18 mm in the 
trachea, to 0.7 mm at generation 14 and 0.3 mm at the alveolar ducts. Hence, there is a 
significant increase in the surface area for gas exchange, which may be as great as 143 m2 in 
the average male (Weibel, 1984).  
As the airways narrow, the resistance (pressure ÷ flow) to airflow increases along a single 
airway. In reality though, the highest resistance is found in the large central airways, whilst 
the resistance in the peripheral airways accounts for only 20% of the total resistance due to 
the increased cross-sectional area of the millions of peripheral airways in parallel. In the 
large airways, where air moves by bulk flow, a turbulent airflow pattern predominates, thus 
increasing resistance, whilst in the peripheral airways, diffusion is the predominant means 
for moving gas (Fig 3). 
As the respiratory bronchioles and alveolar ducts contribute little to the overall resistance of 
the lungs as a whole, the distribution of gas within these units is determined principally by 
the compliance of the lungs (CL)—a measure of stiffness or floppiness of the object  (CL 
=volume  pressure). In normal lungs, the pressure-volume relationship is such that each 
tidal breath occurs at the steep part of the relationship, where compliance is high (Fig 4).  
www.intechopen.com
 
Cystic Fibrosis – Renewed Hopes Through Research 
 
496 
 
Fig. 3. The relationship of airway cross-sectional area and airflow velocity to airway 
generation in the human lung. As the airways branch, the total cross-sectional area increases 
from 2.5 cm2 in the trachea, to around 13 cm2 at the tenth generation (1024 airways) with a 
final cross-sectional area of around 300 cm2 in the acinar region. The airflow velocity falls by 
more than 100-fold from the trachea down to the acinus (1 m.s-1 to 1 cm.s-1). In exercise, the 
airflow velocity may be up to ten times greater and so greater airflow is observed within the 
acinus. Data from various sources. 
 
Fig. 4. Schematic of pressure volumes curves in normal subjects (N) and in patients with CF. 
In normal subjects, for the change in pressure (P1 = P2) there is a greater change in volume 
at P1 than for P2 demonstrating that the compliance of the lungs is greater at P1 than at 
P2. Normal tidal breathing occurs on the steeper portion of the pressure-volume curve. In 
CF, the pressure volume curve is altered – there is normal compliance of the lungs over the 
normal tidal volume range, but reduced compliance at high lung volumes (summary data 
from Mansell et al, 1974) 
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When we breathe in close to maximum, the pressure-volume relationship is much flatter 
(more pressure needed to increase a given volume) and so it is much harder to breathe, 
making the work of breathing greater. On the other hand, when we breathe fully out, the 
pressure-volume curve is much steeper, indicating that full exhalation is not limited by lung 
compliance. One key point on this curve is the end-expiratory lung volume (EELV) or 
functional residual capacity (FRC). This is the equilibrium point in the relationship between 
the outward pull of the chest wall and the inward collapse of the lungs, where the relative 
magnitudes are equal, but opposite. 
If we apply this observation to an individual alveolus, then the larger it is at the start of tidal 
inhalation, the stiffer (less compliant) it is and so less air enters the alveoli. This is observed 
by looking at the distribution of inspired air, which goes preferentially to the more 
complaint lung bases. In addition to the compliance, ventilation is further distributed within 
the alveolar units by the pores of Kohn, which connect the alveoli within a lobe; this is 
referred to as collateral ventilation. (Desplechain et al, 1983). This should permit equilibrium 
of gas pressures in different lung regions, but this only appears to apply in diseased lungs, 
as in normal lungs the flow resistance of the collateral pathways is high, and so movement 
of gas via this route is minimal. (Macklem, 1971). These pores allow transfer of gas between 
alveoli and function to minimize the collapse of lung units if a more central airway becomes 
blocked. (Hogg et al, 1969).  
One aspect of ventilation that is affected by respiratory disease is the work of breathing. 
(Campbell et al, 1957; Milic-Emili, 1991).  During the passive expiration of a normal 
resting tidal breath, the work of breathing is performed entirely by the inspiratory 
muscles. Approximately 50% of the work during inspiration is dissipated as heat in 
overcoming the frictional forces that oppose inspiration. The remaining 50% is stored as 
potential energy in the deformed elastic tissues of the lungs and chest wall, as they are at 
a point above the EELV and hence are not in equilibrium. This potential energy is 
available for expiration and is dissipated as heat in overcoming the frictional forces that 
resist expiration. 
Energy that is stored in the deformed elastic tissue allows the work of expiration to be 
transferred to the inspiratory muscles. The actual work performed by the respiratory 
muscles is very small ( 3 ml.min-1 O2), compared to the average resting oxygen uptake of 
250 ml.min-1, and so accounts for only about 1 – 2% of the resting metabolic rate. 
The work of breathing overcomes two main problems—the elastic recoil of the lungs and 
chest wall, and the airway resistance to gas flow. The total work of breathing is the sum of 
the elastic and resistive work and may be related to lung volume or breathing frequency 
(Fig 5). It is likely that each individual selects the most appropriate breathing frequency in 
order to minimize the work of breathing. 
3. Mucus clearance mechanisms 
When the lungs are ventilated they are exposed to a vast range of particulate matter, 
bacteria and viruses. The main defence mechanism against these is the viscous mucus layer, 
which provides a physical protective barrier to chemical damage of the epithelium (Foster, 
2002; Rubin, 2002).  
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Fig. 5. Schematic diagram of the relationships of work of breathing against lung volume (A) 
and breathing frequency (B). The total work of breathing is the summation of the elastic 
properties of lungs and chest wall and airway resistance components. In normal subjects, 
there will be an optimal lung volume and optimal breathing frequency which is probably set 
for each individual. The effects of obstructive and restrictive lung disorders are shown for 
both relationships. 
Airway mucus is a complex substance that lines the respiratory tract. Bacteria and other 
airborne particles become trapped in this sticky mucus and then are swept upwards and 
outwards by the tiny hair-like structures - cilia. The interaction between normal mucus, cilia 
and associated structures make up the mucociliary clearance system (MC).  
Many inhaled irritants simply dissolve in the mucus, whilst inhaled particles are deposited 
in the airways either by impaction or sedimentation. These particles are then degraded by 
the proteases in the mucus or removed intact by the mucus. In the smaller airways 
sedimentation occurs due to the low airflow, so the particles are deposited and removed by 
macrophages.  
For bacteria and viruses, the first line of defence is the physical removal by the mucus. 
Within the mucus, humoral defences include immunoglobulins, protease inhibitors and 
endogenous antibiotics. The airway provides numerous defence mechanisms to prevent 
microbial colonization by the large numbers of bacteria and viruses present in ambient air. 
Important components of this defence are the antimicrobial peptides and proteins present in 
the airway surface fluid—the mucin-rich fluid covering the respiratory epithelium (Rose & 
Voynow, 2006; Voynow & Rubin, 2009). Recently, evidence has indicated that within the 
airways of normal subjects is an endogenous antibiotic—human defensins, which is 
believed to play an important role as part of the airway defence mechanisms (Schneider et 
al, 2005). Human β-defensin gene (HBD-2) represents the first human defence that is 
produced following stimulation of epithelial cells by contact with micro-organisms, such as 
Pseudomonas aeruginosa, or cytokines, such as tumour necrosis factor- (TNF-) and 
Interleukin-1 (IL-1) (Laube et al, 2006). Cellular immunity is also in evidence throughout 
the epithelium with macrophages, neutrophils and lymphocytes commonly occurring 
during infections in the normal lung. 
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Respiratory health is dependent on consistent clearance of airway secretions (Wanner et al, 
1996; Houtmeyers et al, 1999). A healthy MC moves respiratory secretions to central 
airways, with the final clearance achieved by a combination of coughing and swallowing.  
3.1 Cough and expiratory flow 
Cough may be increased in respiratory infection and assists in clearing the airways from 
generations 7 - 8 upwards, augmenting the MC when overwhelmed by copious secretions.  
Cough is a normal reflex mechanism that commences with a brief rapid inspiration usually 
greater than the resting tidal volume, this volume being sufficient for expiratory activity. 
(Ross et al, 1955; Bennett et al, 1990; Bennett & Zeman, 1994).  The glottis closes for about 200 
ms. There is an associated sharp rise in both pleural and abdominal pressure to between 6.6 
to 13.3 kPa, resulting from expiratory muscle and diaphragmatic contraction; lung volume is 
held constant. Glottal closure limits expiratory muscle shortening, so promoting the 
isometric contraction of the expiratory muscles. This allows the expiratory muscles to 
maintain a much more advantageous force-length relationship, resulting in the generation of 
greater positive intra-abdominal and intrathoracic pressures, which may be up to 40 kPa.  
Once the glottis is opened, the expiratory phase of cough occurs. The high intrathoracic 
pressures developed during the compressive phase promote high expiratory flow rates. 
Initially, there is a very brief blast of turbulent flow. This initial peak of expiratory flow lasts 
for between 20 ms to 50 ms and the cough Peak Expiratory Flow (cPEF) may exceed 720 
l.min-1 (Fig 6). This burst of air is due to the additive effects of the gas expired from the 
distal parenchymal units and the gas displaced by the more central airways, which are 
compressed by the high intrathoracic pressures. (Knudson et al, 1974). Although glottal 
closure enhances this phase of cough, it is not essential for an effective cough. (Von Leden & 
Isshiki, 1965). After the initial explosive burst of air, a period of between 200 to 500 ms 
occurs with much lower expiratory flows of between 180 to 240 l.min-1. During this period, 
lung volume, transpulmonary pressure and cough expiratory flows all decrease.  
As expiratory flow rate decreases, the airflow velocity changes—the relationship being 
dependent on the cross-sectional area of the airways (velocity = flow  cross-sectional area). 
As shown in Fig 3, the peripheral airways have the largest cross-sectional area, whilst the 
larger bronchi and trachea have a much lower cross-sectional area. Hence as the cross-
sectional area of the airways decreases, the velocity of air increases for a given expiratory 
flow rate. In other words, the velocity of the gas increases as the air moves from the 
peripheral to the central airways.  
Gas velocity may be further enhanced in the central airways due to dynamic airway 
compression, where the airway narrows due to the pressure surrounding it being greater 
than the pressure within it. Narrowing the airway reduces the cross-sectional area, and so 
velocity increases for a given flow rate. 
In normal airways, and during resting tidal breathing, the velocity of air is around 500 cm.s-1 
down to the airway generations 7 to 8 (Fig 3). At the peak of cough the velocity of air may 
exceed 16,000 cm.s-1. The cough lasts for approximately 0.5s: up to 1 litre of air may be 
expelled and the cough is ended either by glottal closure or respiratory muscle relaxation, 
with a consequent fall in pleural pressure (Fig 6). Often there are further small coughs, 
which diminish in intensity as lung volume declines towards residual volume. 
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Fig. 6. A) Measurements taken during a cough and the preceding inspiration of a healthy 
male subject. From top to bottom: volume flow of air; oesophageal pressure; resistance to 
airflow (P/flow). The inspiratory phase lasts about 0.65 seconds and resulted in an intake 
of about 2.5 litres of air. Following a short period of glottal closure (about 0.2 sec.) about the 
same volume of air was expelled within 0.5 sec. During inspiration, the change in 
intrapleural pressure measured using the oesophageal balloon rarely exceeded - 20 mmHg 
but, during expiration, the change reached between +100 to 140 mmHg. Maximum 
inspiratory flow rates were 3 - 4 l.s-1 and expiratory flow rates reached maxima of 5 - 6.5 l.s-1. 
(From Ross et al, 1955 with permission). B) Coughs performed by a subject, either voluntary, 
shutter, or huff, was recorded by having the subject cough into a rolling seal spirometer. On 
average an airway pressure of +70 cmH2O was required. Finally, the partial forced 
expiration or huff was performed in the same manner but without glottal closure. These 
manoeuvres are superimposed upon the subject’s normal flow volume curve (From Bennett 
& Zeman, 1990 with permission) 
In relation to mucous clearance, the actual velocity of airflow through the airways alters the 
kinetic energy (KE) available. As KE = mv2  2, (KE  v2), where m is the mass of the object 
and v the velocity, a doubling of the velocity will result in a fourfold increase in the KE. So, 
the effects of dynamic compression are such that a narrowing of the airways results in an 
increase in velocity, which in turn results in increases in kinetic energy, thus enhancing the 
removal of mucus adhering to the airway wall. Zahm et al (1991), using a simulated cough 
device, found that the displacement of artificial mucus following a simulated cough was 
greater at smaller airway diameters. Hasani et al (1994) observed that during expiratory 
flow, mucus transport was more efficient in the central rather than the peripheral airways. 
In order to understand how airway clearance devices may be used to assist in the removal of 
these secretions, we need to understand how cough works in reality. Cough is effective in 
removing mucus and particulates if the secretions lining the airways are dispersed into the 
expiratory gas. The high velocity of airflow interacts with the bronchial secretions, resulting 
in ‘two-phase air-liquid flow’ by which energy is transferred from the air to the liquid, 
resulting in a shearing effect on the liquid secretions, thus aiding the expectoration of 
sputum (Clarke et al, 1970; Kim et al, 1986). At velocities of between 1000 – 2500 cm.s-1 an 
annular type of two-phase flow occurs, whilst at a velocity of > 2500 cm.s-1 a mist flow with 
aerosol formation occurs (Fig 7).  
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A number of factors may be observed -  
1. Airways are collapsible structures and so may vibrate and their walls may approximate 
each other, further aiding the loosening of mucus and promoting clearance (McCool & 
Leith, 1987); 
2. Shearing and expectoration are affected by the viscosity, elasticity and surface tension 
of the bronchial secretions in a highly complex manner. (Scherer, 1981).  
3. Waves of mucus have been observed in the range of airflow occurring during a cough 
(King et al, 1985) which may further enhance particle clearance (Kim et al, 1983);  
4. The physical properties of mucus also affect cough efficiency. Mucus clearance is 
directly proportional to the depth of the mucus, and is inversely proportional to its 
viscosity and elasticity (King et al, 1985; King, 1987; King et al 1989; King et al, 1990; 
Albers et al, 1996)  
5. Through use of radiographic methods to measure flow and tracheal cross-section 
during coughing, an index of ‘scrubbing action’ has been derived (Harris & Lawson, 
1968). In healthy subjects during the first cough, around 59% of the scrubbing action 
occurs, with only 26% and 16% for the second and third coughs in a sequence of 
coughs. 
6. During a forced expiration, high expiratory flow develops within about 100 ms and 
results in a high shear rate. Mucus transport varies inversely with shear rate, referred to 
as pseudoplastic flow or shear thinning. This observed decrease in viscosity can be 
explained by a temporary realignment of macromolecular glycoproteins due to the 
applied force (Lopez-Vidriero, 1981). Therefore, repeated forced expirations with short 
time intervals between each forced expiration may result in a reduction of the mucus 
viscosity and hence improve mucus transport (Zahm et al, 1991).   
In healthy individuals, the rate of mucus secretion is carefully balanced with mucus 
clearance. The consistency of mucus is maintained such that it is thick enough to trap 
bacteria and other inhaled particles but thin enough to be moved easily by cilia. When 
airways are kept free of bacteria, other particles and excess mucus, airways remain open and 
permit normal gas exchange. 
When mucus secretion and mucus clearance are not in balance, excessive airway mucus can 
cause serious problems. Excess, often sticky mucus may accumulate in the airways, 
resulting in an increase in the work of breathing. Regardless of the causes, the consequences 
for the patients are the same—a vicious cycle of recurrent, worsening episodes of 
inflammation, pulmonary infection, increased production of excess mucus, and airway 
obstruction, lung damage and respiratory failure. 
The consequences of uncleared airway secretions in the airways are a clear link between 
mucus hypersecretion/secretion retention, exacerbation of illness, hospitalization, a sharply 
declining one second forced expiratory volume (FEV1) and death (Annesi & Kauffmann, 
1986; Lange et al, 1990; Prescott et al, 1995; Vestbo et al, 1996). The recognition of the clinical 
significance of excessive, abnormal, or retained airway secretions provides the rationale for 
improving mucociliary clearance as a logical treatment goal in order to avoid mucus 
retention and to prevent or break the life-destroying cycle of recurrent infection and 
progressive pulmonary deterioration. 
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Fig. 7. Effects of gas flow rates on a mixture of gas and liquid flowing through a horizontal 
tube. At low flows, bubbles of gas may be dispersed in the liquid (bubble flow). As the gas 
flow rate increases, the bubbles become larger and fill most of the tube cross section; these 
gas ‘slugs” alternate with volumes of liquid and are displaced toward the top of the tube 
(slug flow). At higher flows the gas slugs merge randomly, leading to the liquid occupy the 
lower part of the tube with a fairly smooth surface (stratified flow), which as the flow-rate 
increases further lead to marked surface roll waves appear (wavy flow). With continued 
increases in flow rates the film of liquid is covered by a dense array of small waves and the 
surface may appear smoother although there is extreme agitation of the liquid (annular 
flow). At extreme flow rates, the liquid waves are entrained and blow through the tube in 
the form of droplets (mist flow). (From Clarke et al, 1970 with permission). 
4. Cystic fibrosis  
There are a number of significant changes that occur in patients with CF in terms of the 
respiratory physiology and the mucociliary clearance mechanisms. 
4.1 Respiratory physiological changes in CF 
The changes that occur to the normal physiology are principally airflow obstruction, which 
worsens as the disease progresses. In patients with virtually normal spirometry, evidence of 
mild airways disease is observed by changes in airflow within the small airways, as 
measured by the Maximal Expiratory Flow (MEF) with 25% of the Forced Vital Capacity 
(FVC) remaining1. This is known as the MEF25%FVC (Zapatal et al, 1971). In terms of gas 
exchange function there is widening of the alveolar-arterial PO2 (AaPO2) and an increased 
dead space to tidal volume ratio (VD/VT) (Lamarre et al, 1972). Whilst the total lung capacity 
(TLC) is often normal (Reis et al, 1988), the static pressure-volume curve (compliance) shows 
a loss of recoil pressures at low lung volumes with normal recoil pressures at high lung 
volumes. (Mansell et al, 1974). This results in a normal compliance of the lungs over the 
normal tidal volume range, but reduced compliance at high lung volumes (Fig 4). 
                                                 
1The MEF25%FVC is obtained from a maximal expiratory flow volume curve. The subject inhales fully and 
then forcibly exhales. The volume of air exhaled in total is the forced vital capacity (FVC). With 25% of 
the FVC remaining, the flow rate at this point can be obtained and hence is the MEF25%FVC. In the US this 
is referred to as the forced expiratory flow (FEF) after 75% of the FVC has been exhaled (FEF75%FVC).  
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Despite malnutrition being common in CF patients, respiratory muscle weakness is not 
common, and, if present, is generally mild. (Mier et al, 1990). This is important as cough is 
common in CF with median rates being 21.2 coughs.h-1 (interquartile range [IQR] 14 – 34.9) 
at the time of exacerbation, but reducing to a median of 9.0 coughs.h-1 (IQR 5.8–12.8). (Smith 
et al, 2006) The other major abnormality of note is that exercise capacity is often limited by 
the combined effects of airflow obstruction and muscle wasting due to malnutrition. (Lands 
et al, 1992). As indicated above, the small airways may have reduced function (MEF25%FVC).  
The causes of this small airways disease are possibly the result of significant increases in the 
inner wall and the smooth muscle areas of the peripheral airways. (Tiddens HA, et al, 2000) 
Changes in the airway dimensions of CF patients compared to chronic obstructive lung disease 
(COPD) patients showed that, for airways of 1.9 mm diameter (12th generation), there was an 
approximately fivefold increase in the smooth muscle area and a threefold increase in the inner 
wall area without epithelium. In the larger airways (35 mm diameter) there was a 1.5 increase 
in smooth muscle area with an almost identical inner wall area without epithelium. These 
changes may also be related to age (Soboya & Tausig, 1986). Finally, the work of breathing is 
increased, although the increase is not solely explained by changes in lung function and lung 
mechanics (Fig 8), but also by the effects of TNF- and CFTR (Bell et al, 1996).  
These pathological studies demonstrate the variability of the destructive processes in the 
lungs of CF patients. Airway wall thickening is a marked feature of CF and is likely to 
extend into the small airways and be associated with airways inflammation and obstruction.  
4.2 Mucus and mucociliary clearance in CF 
In CF, there is increased mucus retention and bacterial colonization, due to the viscous 
nature of the mucus. However, there is inhibition of antimicrobial peptide activity or gene 
expression can result in an increased susceptibility to infections where the CF phenotype 
leads to reduced antimicrobial capacity of peptides in the airway. (Goldman et al, 1997; 
Rosenstein & Zeitlin, 1998). Thus in CF, bacterial colonization and mucus hypersecretion 
occur as a consequence, leading to progressive lung damage (Tiddens et al, 2000)  
 
Fig. 8. Summary data on resting energy expenditure and oxygen cost of breathing in control 
subjects and patients with CF. The data shown (means only) shows that CF patients have a 
significantly higher respiratory rate (RR; breaths.min-1: p<0.05), minute ventilation (VE; 
l.min-1: p<0.001); oxygen uptake/kg (VO2/kg; l.min-1.kg-1: p<0.001) and resting energy 
expenditure/kg (REE; kJ.min-1.kg-1: p<0.001) and O2 cost (ml.l-1 VE). (From Bell et al, 1996).  
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Patients with CF have impaired airway clearance due to the following problems: 
1. Ineffective ciliary clearance: Normal cilia beat in a coordinated unidirectional fashion 
to mobilize mucus and clear particulate matter from the airways. Damaged cilia 
perform this function inadequately or not at all;  
2. Excessive or abnormal mucus production: CF results in excess mucus production and 
the mucus is abnormally thick and sticky. Large quantities of mucus, or mucus with 
altered physical properties, may overwhelm the mucociliary apparatus, inhibiting 
normal airway clearance (Rose & Voynow, 2005; Voynow & Rubin, 2009);  
3. Ineffective cough: Cough function may be weak or ineffective if the muscles have 
become weak or fatigued; 
4. Obstructive lung disease: The airway size is decreased as a result of structural changes, 
bronchospasm and excess mucus, limiting the ability to exhale. These effects result in 
much slower clearance of mucus than in normal subjects, (Regnis et al, 1994; Matthys & 
Kohler, 1986; Yeates et al, 1976; Wood et al, 1975) with a correlation between the lung 
function and mucociliary clearance (Robinson et al, 2000; Fig 9).  
Because at-risk individuals are prone to recurrent episodes of respiratory inflammation, 
infection and, eventually, irreversible lung damage, improvement of MC is an essential goal 
of any treatment plan. Importantly, it is a goal that can be achieved by the individual and 
must include effective airway clearance therapy.  
 
Fig. 9. Percentage of radioactivity cleared from different regions of the right lung at 60 
minutes in normal subjects (black columns) and in patients with CF (grey columns). In A), 
the differences are observed for the whole lung (WL), Central (C), Intermediate (Int) and 
peripheral (Periph) airways. In B), the same regions as in A) are shown in relation to the 
degree of airway dysfunction in CF patients – normal small airway function (NSA; FEV1  
80%pred and FEF25-75  80%pred)2, normal spirometry (NSP; FEV1  80%pred and FEF25-75 < 
80%pred), moderate (Mod; 40%  FEV1 < 80%pred) and severe (Sev; FEV1 < 40% pred) lung 
disease. There is no data for NSP – peripheral. Redrawn from Robinson et al, 2000)  
                                                 
2The FEF25-75% is the flow rate during a maximal forced exhalation and represents the averaged flow 
rates between 75% and 25% of the FVC.   
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5. Airway clearance devices 
A number of adjunctive techniques and devices have been used to assist those who are 
unable, for whatever reason, to clear pulmonary secretions effectively and have been 
extensively reviewed (Cystic Fibrosis Trust, 2003; Yankaskas et al 2004; Kendrick, 2007; van 
der Schans, 2007; Bott et al, 2009; Flume et al, 2009; Daniels, 2010).  
5.1 Criteria for airway clearance devices  
The key to any device used to clear secretions is that it meets a number or criteria, based on 
the physiology. These criteria are: 
1. Increase absolute peak expiratory flow (PEF) to move secretions towards the 
oropharynx; 
2. Use of two-phase gas–liquid flow, both in closed and open airways. In the latter, mucus 
transport can be achieved by expiratory airflow during forced expiration, as well as 
tidal breathing. The peak expiratory flow/peak inspiratory flow ratio (PEF/PIF) needs 
to be > 1.1 to achieve this (Kim et al, 1986; Kim et al, 1986a; Kim et al, 1987) and the 
frequency of oscillation needs to be between 3 – 17 Hz, with the ideal frequency being 
around 13 Hz (Gross et al, 1985) 
3. Decrease the mucus visco-elasticity in the airway, and hence improve mucus transport 
(App et al, 1998) 
4. Elicit spontaneous coughs by mechanical stimulation of the airways to remove mucus 
from the trachea, inner and intermediate regions of the lungs (Laube et al, 2006; Hasani 
et al 1994)  
5. Increase expectorated mucus volume (Konstan et al, 1994).  
However, what all of these are dependent upon is the mechanical properties of the lungs of CF 
patients, which may deteriorate with disease progression (Arora & Gal, 1981; van der Schans, 
1997). This might mean alternative approaches have to be adopted, and although these above 
criteria are the “ideal” criteria, there are alternative approaches which use different criteria and 
which may work as well or better. What is important is that we understand the criteria that 
each device achieves, how it may be adapted to an individual patient’s needs and that 
changing the device as the disease progresses should always be an option worth considering. 
5.2 Physiological aspects of airway clearance devices   
Perhaps surprisingly, there are virtually no studies that have investigated exactly how these 
devices work from the physiological viewpoint and hence our understanding of how we are 
applying these devices into clinical practice is limited. Recently, McCarren et al (2006a, b, c) 
have provided evidence of how a variety of techniques work physiologically. These three 
studies conclude: 
1. Chest wall circumference changed by 0.8 cm, the frequency of vibration was 5.5 Hz, the 
PEF was 58.2 l.min-1 and the PEF/PIF ratio was 0.75, all of which are well below the 
ideal criteria for removing mucus (McCarren et al 2006a). What this study 
demonstrated was that the PEF during vibration was 50% greater than from a relaxed 
TLC manoeuvre and was composed of the flow rate due to a) elastic recoil, b) chest wall 
compression and c) chest wall oscillation. When summed, these three contributors 
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equated to the PEF observed during vibration, the proportional contributions being 
67%, 15% and 14%, respectively;  
2. There were clear relationships between the external chest wall force applied, chest wall 
circumference, intrapleural pressure (Fig 10) and expiratory flow (McCarren 2006b).   
Similar to the previous reference (McCarren et al 2006a),  the intrapleural pressure 
observed was composed of the sum of the lung recoil, compression and oscillation 
components, the proportional contributions being 75%, 13% and 12%, respectively.  
These two studies (McCarren et al 2006a; McCarren et al 2006b) have demonstrated some 
important relationships between the mechanics of the lung and the potential to remove 
sputum. The flow rates generated by vibration would be insufficient to augment secretion 
clearance by annular flow, since the PEF/PIF ratio was 0.75 and needs to exceed 1.1 (Kim et 
al, 1987). Why the inspiratory flow bias occurred is unclear, but may be related to the way in 
which physiotherapists ask the patient to take a deep breath. The frequency of vibration is 
also much lower than the ideal of between 11–15 Hz (Gross et al, 1985). It is currently 
unknown whether this vibration frequency would have a significant influence on the 
sputum rheology, but any decrease that may occur is likely to enhance the ability of cilia to 
move mucus (Wanner et al, 1996).  
 
Fig. 10. A) The time course of the expiratory flow of the interventions in one subject. The 
eight traces have been separated vertically for clarity. HuffHIGH: huff from high lung 
volumes; TLCrelax: total lung capacity passive expiration; PEP: positive expiratory pressure. 
B) Summary of data comparing measured data for PEF/PIF ratio and frequency of 
oscillation in various methods of airway clearance. The vertical dashed line is the ideal 
frequency range for the methods, whilst the horizontal dashed line is the minimum ideal 
PEF/PIF ratio. From McCarren et al, 2006b, with permission. 
In normal subjects, expiratory flows are enhanced by lung recoil due to the additional forces 
applied to the chest wall during vibration by manual compression and oscillation. Where 
there is increased mucus and more viscous secretions, the airways will have a reduced 
airway radius and airway resistance will be increased.  
Physiologically, these observations can be explained using Poiseuille's Equations (Resistance  
1/airway radius4 and Flow  radius4). If the airway narrows (smaller radius), there will be an 
increase in the resistance to airflow, and a reduction in airflow. Furthermore, Poiseuille's 
Equation includes a term for viscosity (η) on the denominator, and therefore changes in the 
viscosity of the mucus will potentially further alter the resistance and flow rates of air. 
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The third study in CF patients, (McCarren et al, 2006c) investigated vibration, percussion, 
PEP device, flutter, VRP valve and Acapella PEP. In addition, forced expiratory manoeuvres 
were voluntary cough and huff from high lung volumes (huffHIGH). The important new 
measurements were inspiratory and expiratory flow rates recorded during the manoeuvres 
and the oscillation frequency determined by frequency spectral analysis. The key findings of 
this study were –  
1. The PEF of vibration (1.58 ± 0.73 l.s-1) was greater by 1.4 (flutter: 1.13 ± 0.3 l.s-1) to 3.6 
times (PEP: 0.44 ± 0.15 l.s-1), but cough PEF was 4.67 ± 1.19 l.s-1and huffHIGH PEF was 
5.04 ± 2.3 l.s-1; 
2. The frequency of oscillation ranged 6.5–18.3 Hz, with flutter and Acapella devices 
having the higher oscillation frequencies (Fig 10). 
None of these devices achieved the ideal combination. Vibration did not achieve the critical 
PEF/PIF of > 1.1, nor the critical optimal frequency (8.4 Hz). PEF was reduced due to the 
added resistance presented to expiration. However, the added resistance may result in 
stabilization of collapsible airways and allow for collateral ventilation to occur between 
alveoli via the Pores of Kohn, resulting in an increase in gas volume behind the mucus and 
hence aiding the movement of the secretions (Fink, 2002; Delaunois, 1989). As with the 
devices assessed, cough and huffHIGH do not achieve the ideal intervention status, as they do 
not oscillate airflow; increasing cilia beat frequency and/or decrease mucus viscosity.  
Previous studies looking at the oscillation frequency using bench testing have noted that, for 
the Acapella and Flutter devices, the frequencies range from 8 – 25 Hz (Acapella blue), 13 – 
30 Hz Acapella green) and 15 - 29 Hz (Flutter) (Volsko et al, 2003). More recently, Alves et al 
(2008) has demonstrated that the angle of use of the Flutter VRP1 may influence the 
outcome and treatment application.  
With the limited physiological studies, the remaining question that has been answered to 
some extent is whether or not these devices alter sputum rheology (App et al, 1998). Using 
the flutter device and comparing changes in the characteristics of sputum, this study 
showed that the elastic properties of CF sputum samples were affected significantly by 
application of oscillations generated by the flutter at 15 and 30 min (Fig 11). The median 
frequency of the flutter-generated oscillations was 19 Hz.  
These findings suggest that applied oscillations are capable of decreasing mucus visco-
elasticity within the airways at frequencies and amplitudes achievable with the flutter 
device, and provide direct evidence of changes in the visco-elasticity of sputum. 
Whilst the ideal frequency may be around 13 Hz, there is new evidence that suggests that a 
combination of 1) a higher frequency causing the airways to vibrate, resulting in the 
loosening (shearing) of the mucus from the airways, and 2) applying minimal positive 
pressure (+ 1 cmH2O) via the Pores of Kohn and hence through the use of collateral 
ventilation, aids mucus clearance (Clini, 2009). This is clearly demonstrated in Fig 12 using 
lung ventilation scintography (Fazzi et al, 2009) 
One of the other ways of removing excess sputum from the airways is by increasing airflow 
along the airways. During normal tidal breathing the airflow can be artificially increased by 
applying a venturi effect within a breathing circuit, and this increase in the velocity of the air 
can enhance the movement of sputum. This is achieved because the movement of air above 
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a layer of mucus develops a shearing force over the surface of this liquid layer. When the 
shearing force exceeds the surface tension in the mucous layer, the mucus starts to move in 
the direction of the air flow (Kim et al, 1987). As the mucus moves up the bronchial tree, it 
will eventually be swallowed. Importantly, this effect can be achieved with minimal 
discomfort and without the need to cough. Where a patient’s clinical condition is 
deteriorating and they have fatigued muscles, the cough PEF may well be reduced to the 
extent that clearing secretions is inhibited significantly. A device that removes excessive 
airway secretions only under tidal breathing conditions would obviate the need for cough.  
 
Fig. 11. Studies using Autogenic Drainage (AD) and Flutter therapy after an acute session at 
the start and end of 4 weeks of therapy, followed by a crossover to 4 weeks of treatment 
with the other therapy. A) Changes in sputum visco-elasticity and B) Mucus clearability 
indices, where the mucociliary clearance index (M.C.I.) and cough clearability index (C.C.I.) 
were calculated from sputum viscoelastic data. From App et al, 1998, with permission. 
 
Fig. 12. Dynamic ventilation obtained using lung ventilation scintography (anterior scan) 
over 30 min during Temporary Positive Expiratory pressure (TPEP) therapy in a patient 
with COPD. Note how the central deposition of mucus plugs (dark areas) progressively 
clears over time. From Fazzi et al, 2008. 
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5.3 Do airway clearance techniques work in reality? (Cochrane reviews) 
The range of techniques has recently been evaluated in six Cochrane reviews (Van der 
Schans, et al, 2000; Elkins et al, 2004; Main et al, 2005; Moran et al, 2009; Morrison & Agnew, 
2009; Robinson et al, 2010). The conclusions from these Cochrane reviews are that: -  
1. Airway clearance is important in the short term for patients with CF, but the long-term 
effects of no airway clearance is unknown;  
2. Conventional chest physiotherapy is as effective as other forms of airway clearance; 
3. Patients like their independence, and therefore any technique which they themselves 
can use is preferred; 
4. Oscillation devices were no more or no less effective than other forms of physiotherapy; 
5. There is not enough evidence to conclude, one way or the other, that Active Cycle of 
Breathing Techniques (ACBT) are any better or worse than any other technique. 
6. Non-Invasive Ventilation (NIV) appears to help patients clear sputum more easily than 
other airway clearance techniques, and particularly in those patients who have 
difficulty in expectorating sputum. 
What is somewhat disheartening in all of these reviews is the almost complete lack of really 
good quality research, and it is important to ensure data is collected appropriately and the 
primary and secondary outcome measures are available in order to fully understand the 
effects of any intervention.  
These findings are confirmed in the review by McCool and Rosen (2006) where much of the 
level of evidence for airway clearance devices is fair to low and the benefits were 
intermediate to conflicting. 
What is consistent in these studies is that, regardless of the device used, or the way in which 
the trial was conducted, there appears to be little change in the observed primary, and in 
many cases secondary, outcome measures. However, what makes these studies difficult to 
compare is the complete lack of commonality between recruitment, methodology, primary 
and secondary outcome measures, severity of disease, etc. This makes setting evidence-
based practice guidelines interesting and limited in their conclusiveness. 
5.4 Mathematical modelling 
Whilst considerable work has been undertaken with studies on patients, other work has 
looked at bench testing and modelling some of the airway clearance techniques.  
High Frequency Chest Compression (HFCC) has been investigated in such a way. Milla et 
al. (2004) investigated the actual waveform used in HFCC, which previously had been a sine 
wave. Changing to a triangular waveform significantly increased sputum production (4%–
41%, mean 20%). From this small study of eight patients, the authors concluded that further 
investigation in patients using the sine and triangular waveform should be undertaken to 
determine the best frequencies for each waveform, disease and patient. They also pointed 
out that the original, and now neglected, square wave should be reassessed. 
In a subsequent study (Milla et al, 2006), they investigated which frequency was appropriate 
to use for HFCC in order to ‘tune’ the device with the patient. In 100 patients, they found 
that the highest airflows for the sine waveform occurred between 13 – 20 Hz, with the 
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largest volumes occurring between 6 – 10 Hz. For the square waveform, the highest flows 
and volumes occurred between 6 – 14 Hz. The authors provided a ‘tuning’ protocol for 
prescribing frequencies with the various HFCC machines, because they are different from 
one another. 
Sohn et al (2005) used a computational model to investigate the non-linear effects of airway 
resistance, lung capacitance, and inertness of air on respiratory airflow, with airways 
resistance contributing the greatest effect. 
Bench testing of other devices has been limited to oscillating Positive Expiratory Pressure 
(PEP) devices (Volsko et al, 2003) and HFCC (Lee et al, 2008). In the study of Volsko et al 
(2003), there was a statistically significant difference, but probably not a clinically significant 
difference between mean pressure, pressure amplitude and frequency over a range of 
experimental conditions. At medium flows, there were similar pressure waveforms, and 
hence overall similar performance characteristics.  
Lee et al (2008) investigated the effects of different frequency and pressure waveforms 
using three different HFCC devices, bench tested using a mannequin. They concluded 
that a better understanding of the differences in frequency and pressure amplitude when 
applying devices to patients would allow clinicians and patients to optimize the efficacy 
of HFCC. 
5.5 Which device to use? 
Whatever technique is used to aid airway clearance, its application to a given patient must 
be such that we achieve a balance between the treatment demands and the patient’s lifestyle. 
It is known that there are adherence issues as a result of the increasing time and effort 
required by patient self-management strategies, particularly when adults have to try and 
balance family, work, education etc with managing a chronic disease (Boyle, 2003). Whilst 
adherence to antibiotic treatment is high (80% - 95%), adherence to physiotherapy is low 
(40% - 55%; Kettler et al, 2002: 30%; Myers & Horn, 2006). Of note, airway clearance 
techniques, in adult CF patients, are perceived as a higher treatment burden with only 49% 
of patients performing airway clearance (Sawicki et al, 2009). 
In selecting which airway clearance technique or combination of techniques to use, there are 
a number of key questions that should be taken into consideration –  
1. Is the technique appropriate for the patient’s clinical state and environment?  
2. Is the technique compatible with the patient’s lifestyle? 
3. What does the patient like and dislike about each technique appropriate for use at that 
stage of their clinical status? 
4. Does the patient perceive that the technique actually works? 
5. What is the balance between the cost of the technique and the benefits, efficacy and 
preference of the technique? 
Taking all of these questions into account and listening to the patient and their needs and 
preferences should allow the most appropriate airway clearance technique to be used, with 
or without the addition of behavioural techniques that increase adherence (Bernard & 
Cohen, 2004).     
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6. The future 
Parents of children and adult patients want treatments that will help them achieve optimal 
health and quality of life goals. To make appropriate choices, they require accurate 
information, including a clear description of the theory and technique of available airway 
clearance methods. Additionally, they need information to allow them rule out treatments 
that are likely to be unsuitable based on particular physical or mental limitations and upon 
the psychological, social and economic circumstances of the entire family. Useful decision 
making criteria may include: -  
1. What the patient and medical team want to achieve; 
2. The clinical effectiveness of the technique; 
3. Medical contraindications; 
4. The ease of teaching/learning the technique by the patients and/or by the carer; 
5. The likely acceptability and hence adherence with the technique; 
6. The likely effort/work required by the technique compared to its likely benefit; 
7. The patient’s age, motivation, cognitive ability, concentration level and caregiver 
situation; 
8. The degree of independence that a given technique gives the patient from the carer or 
the medical teams.  
Airway clearance techniques are an essential part of the management of patients with CF. 
However, our understanding of how these devices work from bench testing and from 
physiological studies is limited to a very small number of studies. The studies themselves 
have used different populations (adults, children, mixed), with a range of disease severity 
and in general used the FEV1 as the primary outcome measure. Whilst the FEV1 is useful for 
assessing the respiratory well-being of patients, it presents only a limited picture of airway 
function. The FEF25%–75% has been used, and is thought to be sensitive to abnormalities in the 
small airway (McFadden & Linden, 1972; Landau et al, 1973). This, however, is only true 
when both the elastic recoil of the lungs and airways resistance are normal (Woolcock, 1998).  
This may not be the case in CF, and is probably overlooked when interpreting results. The 
other key point about the FEF25%–75% is that it is very dependent on a true FVC being 
achieved on every occasion, which in itself may also be a significant variable. Furthermore, 
if the FVC increases or decreases then interpretation of this index becomes difficult. An 
alternative is to use the MEF25%FVC which is similarly believed to be sensitive to small airway 
abnormalities. Again, however, if the FVC changes, the MEF25%FVC cannot be compared post 
intervention to pre-intervention. Both these indices need careful analysis pre-to-post 
intervention and this can be achieved by using the iso-volume method of assessment (Boggs 
et al, 1982a; Boggs et al, 1982b).  
Assessing the inhomogeneity of ventilation can be assessed either by nitrogen washout 
(Paiva & Engel, 1981) or by the use of the Lung Clearance Index (LCI) and the mixing ratio 
using the inert gas sulphur hexafluoride (SF6). The second method has been shown to be a 
more sensitive index than spirometry, (Gustafsson et al, 2003) does not require the 
respiratory gymnastics needed for forced expiratory manoeuvres and also appears to be age 
independent (Aurora et al, 2004), thereby making it highly useful for longitudinal studies. It 
is being increasingly used in both adult and paediatric CF patients (Horsley et al, 2008; 
Horsley, 2009; Kieninger et al (2011).  
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Whilst these physiological measurements are important guides to the course of disease, they 
do not present the whole picture. As stated above, what matters to the patient is how much 
independence they have and how much they themselves can actually do. Techniques which 
give the patient greater independence in the management of their own disease may well 
improve adherence to treatment and therapies. Including in studies, measures of patient 
adherence and patient acceptability are equally important.  
Few studies have investigated health-related quality-of life measures, the number of 
exacerbations or hospital days per year, the costs or harm associated with intervention, or 
mortality rates. These need to be included along with the appropriate physiological 
measurements in any properly randomized control trial of airway clearance techniques to 
ensure that we fully understand how these techniques benefit or otherwise patients with CF. 
Furthermore, in our increasingly cost sensitive society, there needs to be a cost-benefit 
analysis included. 
There are new techniques emerging and modifications of existing techniques which will 
improve the already difficult lives of patients with CF. As observed in all of the Cochrane 
reviews there is a clear need for properly controlled randomized trials and sensible and 
carefully selected primary and secondary outcomes that present the whole picture, provide 
the much needed evidence-based information needed to understand and apply these 
techniques. It is therefore incumbent on all researchers and clinicians working with CF 
patients to ensure that this good quality research is undertaken and published. 
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